title: The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery.
abstract: Neuronavigation, today a routine method in neurosurgery, has not yet been systematically assessed in direct comparison with conventional microsurgical techniques. The aim of the present study was the direct comparison of the impact of neuronavigation on glioblastoma surgery regarding time consumption, extent of tumor removal and survival. For each of 52 patients operated for primary glioblastoma with neuronavigation, a patient operated on without navigation was matched. Completeness of tumor resection, including volumetric analysis, was examined by early post-operative MRI. Operating and survival times were obtained for all patients. At a rate of 86.5%, surgeons' opinions about neuronavigation were positive. Operating times were identical in the two groups, while preparation times were 30.4 min longer with navigation. Radiological radicality was achieved in 31% of navigation cases vs. 19% in conventional operations. The absolute and relative residual tumor volumes were significantly lower with neuronavigation. Radical tumor resection was associated with a highly significant prolongation in survival (median 18.3 vs. 10.3 months, p < 0.0001). Survival was longer in patients operated on using neuronavigation (median 13.4 vs. 11.1 months). Neuronavigation increases radicality in glioblastoma resection without prolonging operating time. Regarding the problem of brain shift, neuronavigation should be optimized by intraoperative real-time imaging.
authors.affiliation: Department of Neurosurgery, Ruprecht-Karls-Universität Heidelberg, Germany. rainer_wirtz@med.uni-heldelberg.de
authors.forename: C R
authors.initials: CR
authors.lastname: Wirtz
authors.forename: F K
authors.initials: FK
authors.lastname: Albert
authors.forename: M
authors.initials: M
authors.lastname: Schwaderer
authors.forename: C
authors.initials: C
authors.lastname: Heuer
authors.forename: A
authors.initials: A
authors.lastname: Staubert
authors.forename: V M
authors.initials: VM
authors.lastname: Tronnier
authors.forename: M
authors.initials: M
authors.lastname: Knauth
authors.forename: S
authors.initials: S
authors.lastname: Kunze
mesh_terms: D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D005909:Glioblastoma / Q000401:mortality / Q000601:surgery*; D006801:Humans; D008297:Male; D008866:Microsurgery / Q000295:instrumentation / Q000379:methods*; D008875:Middle Aged; D019635:Neurosurgical Procedures / Q000295:instrumentation / Q000379:methods*; D010043:Outcome and Process Assessment, Health Care; D011446:Prospective Studies; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors; D016896:Treatment Outcome